Arcus Biosciences, Inc. (RCUS) NYSE

22.74

+1.44(+6.76%)

Updated at January 13 04:00PM

Currency In USD

Valuation

Market Cap1.34B
Enterprise Value1.25B
P/E Ratio-6.94
PEG Ratio0.84
Price/Sales Ratio10.23
Price/Book Ratio5.55
Enterprise/Revenue9.65
Enterprise/EBITDA-7.17

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-1.45
Operating Margin-1.56

Management Effectiveness

Return On Assets-0.36
Return On Equity-0.7

Income Statement

Revenue258M
Revenue/Share2.25
Gross Profit258M
EBITDA-269M
Net Income-283M
Diluted EPS-3.14

Balance Sheet

Total Cash831M
Total Cash/Share7.8
Total Debt111M
Total Debt/Equity0.22
Current Ratio3.65
Book Value Per Share4.09

Price History

52-Week Change64.54
52-Week High26.4
52-Week Low6.5
Moving Average 50 Days22.37
Moving Average 200 Days13.39

Statistics

Average Volume1.9M
Shares Outstanding107.98M
% Held by Institutions94.83

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A